117 related articles for article (PubMed ID: 31169098)
1. Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials.
Köhler-Forsberg O; Sylvia LG; Bowden CL; Calabrese JR; Thase ME; Shelton RC; McInnis M; Tohen M; Kocsis JH; Ketter TA; Friedman ES; Deckersbach T; Ostacher MJ; Iosifescu DV; McElroy S; Nierenberg AA
Acta Neuropsychiatr; 2019 Aug; 31(4):230-234. PubMed ID: 31169098
[TBL] [Abstract][Full Text] [Related]
2. White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.
Köhler O; Sylvia LG; Bowden CL; Calabrese JR; Thase M; Shelton RC; McInnis M; Tohen M; Kocsis JH; Ketter TA; Friedman ES; Deckersbach T; Ostacher MJ; Iosifescu DV; McElroy S; Nierenberg AA
Aust N Z J Psychiatry; 2017 Apr; 51(4):355-365. PubMed ID: 27126391
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder.
Köhler-Forsberg O; Sylvia L; Deckersbach T; Ostacher MJ; McInnis M; Iosifescu D; Bowden C; McElroy S; Calabrese J; Thase M; Shelton RC; Tohen M; Kocsis J; Friedman E; Ketter T; Nierenberg AA
Acta Neuropsychiatr; 2018 Oct; 30(5):297-305. PubMed ID: 29212563
[TBL] [Abstract][Full Text] [Related]
4. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
Nierenberg AA; Friedman ES; Bowden CL; Sylvia LG; Thase ME; Ketter T; Ostacher MJ; Leon AC; Reilly-Harrington N; Iosifescu DV; Pencina M; Severe JB; Calabrese JR
Am J Psychiatry; 2013 Jan; 170(1):102-10. PubMed ID: 23288387
[TBL] [Abstract][Full Text] [Related]
5. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
Nierenberg AA; McElroy SL; Friedman ES; Ketter TA; Shelton RC; Deckersbach T; McInnis MG; Bowden CL; Tohen M; Kocsis JH; Calabrese JR; Kinrys G; Bobo WV; Singh V; Kamali M; Kemp D; Brody B; Reilly-Harrington NA; Sylvia LG; Shesler LW; Bernstein EE; Schoenfeld D; Rabideau DJ; Leon AC; Faraone S; Thase ME
J Clin Psychiatry; 2016 Jan; 77(1):90-9. PubMed ID: 26845264
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study of the Effectiveness of Lithium Versus Quetiapine Immediate Release Monotherapy in Patients With Bipolar Spectrum Disorders.
Gao K; Goto T; Yuan C; Brownrigg B; Conroy C; Chan PK; Serrano MB; Ganocy SJ; Fang F; Calabrese JR
J Clin Psychopharmacol; 2018 Oct; 38(5):422-434. PubMed ID: 30102627
[TBL] [Abstract][Full Text] [Related]
7. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
[TBL] [Abstract][Full Text] [Related]
9. Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.
Wrobel AL; Köhler-Forsberg O; Sylvia LG; Russell SE; Dean OM; Cotton SM; Thase M; Calabrese JR; Deckersbach T; Tohen M; Bowden CL; McInnis MG; Kocsis JH; Friedman ES; Ketter TA; Shelton RC; Ostacher MJ; Iosifescu DV; Berk M; Turner A; Nierenberg AA
Acta Psychiatr Scand; 2022 Jun; 145(6):615-627. PubMed ID: 35243620
[TBL] [Abstract][Full Text] [Related]
10. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
Kim SJ; Lee YJ; Lee YJ; Cho SJ
J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
[TBL] [Abstract][Full Text] [Related]
11. fMRI brain activation changes following treatment of a first bipolar manic episode.
Strakowski SM; Fleck DE; Welge J; Eliassen JC; Norris M; Durling M; Komoroski RA; Chu WJ; Weber W; Dudley JA; Blom TJ; Stover A; Klein C; Strawn JR; DelBello MP; Lee JH; Adler CM
Bipolar Disord; 2016 Sep; 18(6):490-501. PubMed ID: 27647671
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes of acute bipolar depressive episode with psychosis.
Caldieraro MA; Dufour S; Sylvia LG; Gao K; Ketter TA; Bobo WV; Walsh S; Janos J; Tohen M; Reilly-Harrington NA; McElroy SL; Shelton RC; Bowden CL; Deckersbach T; Nierenberg AA
Depress Anxiety; 2018 May; 35(5):402-410. PubMed ID: 29329498
[TBL] [Abstract][Full Text] [Related]
13. A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study.
Daglas R; Cotton SM; Allott K; Yücel M; Macneil CA; Hasty MK; Murphy B; Pantelis C; Hallam KT; Henry LP; Conus P; Ratheesh A; Kader L; Wong MT; McGorry PD; Berk M
Eur Psychiatry; 2016 Jan; 31():20-8. PubMed ID: 26655594
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.
Garriga M; Solé E; González-Pinto A; Selva-Vera G; Arranz B; Amann BL; Saiz-Ruiz J; Pérez-Blanco J; Vieta E
Eur Neuropsychopharmacol; 2017 Oct; 27(10):959-969. PubMed ID: 28882405
[TBL] [Abstract][Full Text] [Related]
15. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
16. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
Nolen WA; Weisler RH
Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
[TBL] [Abstract][Full Text] [Related]
17. Brain morphometric features predict medication response in youth with bipolar disorder: a prospective randomized clinical trial.
Lei D; Qin K; Li W; Pinaya WHL; Tallman MJ; Patino LR; Strawn JR; Fleck D; Klein CC; Lui S; Gong Q; Adler CM; Mechelli A; Sweeney JA; DelBello MP
Psychol Med; 2023 Jul; 53(9):4083-4093. PubMed ID: 35392995
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium.
Ketter TA; Miller S; Dell'Osso B; Wang PW
J Affect Disord; 2016 Feb; 191():256-73. PubMed ID: 26688495
[TBL] [Abstract][Full Text] [Related]
20. Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials.
Friedman ES; Calabrese JR; Ketter TA; Leon AC; Thase ME; Bowden CL; Sylvia LG; Ostracher MJ; Severe J; Iosifescu DV; Nierenberg AA; Reilly-Harrington NA
J Affect Disord; 2014 Jan; 152-154():97-104. PubMed ID: 23845385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
